TMCnet News

Recombinant DNA Technology Market Expected to Reach USD 127.3 Billion by 2028: Verified Market Research
[March 13, 2023]

Recombinant DNA Technology Market Expected to Reach USD 127.3 Billion by 2028: Verified Market Research

The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new possibilities and trends in the Recombinant DNA Technology Market.

JERSEY CITY, N.J., March 13, 2023 /PRNewswire/ -- The global Recombinant DNA Technology Market is projected to grow at a CAGR of 7.31% from 2021 to 2028, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 108.3 Billion in 2020 and is expected to reach USD 127.3 Billion by the end of the forecast period.


Download PDF Brochure:

Browse in-depth TOC on "Recombinant DNA Technology Market"

202 - Pages
126 – Tables
37 – Figures

Recombinant DNA Technology: An Innovative Technology that Propels the Global Market for Therapeutics and Agriculture

Recombinant DNA technology, an innovative technology that fuses two separate DNA fragments through recombination, has played a vital role in the development of new vaccines and pharmaceutical products. The agricultural sector has been the most prominent area for the use of recombinant DNA technology, with the development of genetically modified crops such as BT-cotton.

Various factors, including rising demand for protein production, potent therapeutics, and the increasing use of recombinant DNA in medicines, have significantly contributed to the expansion of the global recombinant DNA technology market. The rising prevalence of chronic diseases is expected to drive the demand for medicines and proteins developed using recombinant DNA technology exponentially. Such developments have led to higher investments in research and development of recombinant DNA technology, further propelling the market during the forecast period.

Key players in the global recombinant DNA technology market include Novo Nordisk A/S, Eli Lilly & Company, Sanofi, Amgen Inc, Profacgen, Genscript, Novartis AG, Pfizer Inc, Merck & Co, and Cibus. These companies are constantly engaging in key development strategies, such as partnerships, collaborations, mergers, and acquisitions, to expand their market share and increase their revenue.

Market analysis shows that the global recombinant DNA technology market size is expected to grow at a CAGR of 7.31 during the forecast period 2021 – 2028. The market forecast is based on various factors, including increasing investments in research and development, the rising demand for biopharmaceuticals, and the increasing prevalence of chronic diseases.

The key developments in the global recombinant DNA technology market include the development of new technologies and the launch of innovative products. The market players are focusing on strategic collaborations and partnersips to expand their product portfolios and strengthen their market position.

In conclusion, the global recombinant DNA technology market is expected to witness significant growth during the forecast period due to the rising demand for protein production, potent therapeutics, and the increasing use of recombinant DNA in medicines. The key players in the market are implementing various key development strategies to increase their market share and revenue.

Based on the research, Verified Market Research® has segmented the global Recombinant DNA Technology Market into Product, Component, Application, And Geography.

  • Recombinant DNA Technology Market, by Product
    • Medical
    • Non-Medical
  • Recombinant DNA Technology Market, by Component
    • Expression System
    • Cloning Vector
  • Recombinant DNA Technology Market, by Application
    • Food & Agriculture
    • Health & Diseases
    • Environment
    • Others
  • Recombinant DNA Technology Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Gene Synthesis Market By Method (Solid-phase synthesis, Chip-based synthesis), By Service (Antibody DNA synthesis, Viral DNA synthesis), By Application (Vaccine development, Diseases diagnosis), By End-User (Academic & government research institute, Contract research organizations), By Geography, And Forecast

Viral Vectors And Plasmid DNA Manufacturing Market By Product Type (Viral Vectors, Plasma DNA, Non-Viral DNA Vectors), By Application (Cancer, Inherited Disorder, Infectious Diseases), By End Product (DNA Vaccines, Gene Therapy, Immunotherapy), By Geography, And Forecast

DNA Test Kit Market By Sample Type (Saliva and Cheek Swab), By Application (Ancestry Testing, Diet & Nutrition, Health & Fitness, Disease Risk Assessment), By Geography, And Forecast

DNA Sequencing Electrophoresis System Market By Product (Glass Systems, Plastic Systems), By Application (Chemical Industry, Pharmaceutical Industry), By Geography, And Forecast

Top 10 Vaccine Manufacturers guiding path towards a healthier future

Visualize Recombinant DNA Technology Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Follow Us: LinkedIn | Twitter



Cision View original content:

[ Back To's Homepage ]